InsiderTrades.com logo
When it comes to NVDA… “acceleration cycles” are the key
From DTI   |   Ad
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
Use this link to see Nvidia Unchained right away!

MIRM Insider Trading

Insider Ownership Percentage: 22.87%
Insider Buying (Last 12 Months): $115,064.40
Insider Selling (Last 12 Months): $1,738,025.44

Mirum Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Mirum Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mirum Pharmaceuticals Share Price & Price History

Current Price: $43.69
Price Change: ▲ Price Increase of +1.6 (3.80%)
As of 11/20/2024 01:00 AM ET

This chart shows the closing price history over time for MIRM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Blackrock’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW

Mirum Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/14/2024Jolanda HoweSVPSell2,500$47.10$117,750.002,426View SEC Filing Icon  
9/18/2024Patrick J HeronDirectorBuy115$37.40$4,301.00162,308View SEC Filing Icon  
9/6/2024Patrick J HeronDirectorBuy230$41.58$9,563.40162,193View SEC Filing Icon  
7/2/2024Jolanda HoweSVPSell375$34.00$12,750.002,426View SEC Filing Icon  
6/24/2024Pamela VigInsiderSell30,559$34.00$1,039,006.0027,406View SEC Filing Icon  
6/5/2024Saira RamasastryDirectorSell5,000$25.68$128,400.00View SEC Filing Icon  
3/27/2024Eric BjerkholtCFOBuy2,000$24.80$49,600.0014,000View SEC Filing Icon  
3/25/2024Peter RadovichCOOSell4,303$25.80$111,017.4029,013View SEC Filing Icon  
3/18/2024Eric BjerkholtCFOBuy2,000$25.80$51,600.0012,000View SEC Filing Icon  
2/2/2024Jolanda HoweSVPSell735$26.19$19,249.651,759View SEC Filing Icon  
1/8/2024Christopher PeetzCEOSell5,209$28.03$146,008.27110,125View SEC Filing Icon  
1/8/2024Jolanda HoweSVPSell528$28.04$14,805.12722View SEC Filing Icon  
1/8/2024Lara LongpreInsiderSell1,019$28.04$28,572.76105,254View SEC Filing Icon  
1/8/2024Peter RadovichCOOSell1,408$28.03$39,466.2436,485View SEC Filing Icon  
12/5/2023Jolanda HoweSVPSell2,500$32.40$81,000.00View SEC Filing Icon  
9/14/2023Michael G. GreyDirectorSell14,216$32.00$454,912.00View SEC Filing Icon  
9/11/2023Eric BjerkholtCFOBuy10,000$29.65$296,500.0010,000View SEC Filing Icon  
9/11/2023Patrick J HeronDirectorBuy4,687$30.30$142,016.10152,678View SEC Filing Icon  
8/31/2023Patrick J HeronDirectorBuy147,991$26.25$3,884,763.75147,991View SEC Filing Icon  
8/25/2023Jolanda HoweSVPSell3,459$26.23$90,729.57View SEC Filing Icon  
7/3/2023Christopher PeetzCEOSell5,498$25.65$141,023.70115,334View SEC Filing Icon  
7/3/2023Jolanda HoweSVPSell915$25.65$23,469.753,459View SEC Filing Icon  
7/3/2023Lara LongpreInsiderSell1,004$25.65$25,752.60105,839View SEC Filing Icon  
7/3/2023Peter RadovichCOOSell1,425$25.65$36,551.2537,675View SEC Filing Icon  
5/3/2023Michael G. GreyDirectorSell14,608$28.00$409,024.00View SEC Filing Icon  
11/14/2022Niall O'donnellDirectorSell32,109$19.60$629,336.401,714,888View SEC Filing Icon  
11/11/2022Niall O'donnellDirectorSell174,121$19.99$3,480,678.791,746,997View SEC Filing Icon  
6/6/2022James E FlynnMajor ShareholderSell38,478$25.01$962,334.781,540,190View SEC Filing Icon  
11/26/2021Ian ClementsCFOBuy750$13.90$10,425.00View SEC Filing Icon  
11/24/2021Christopher PeetzCEOBuy7,000$14.40$100,800.00View SEC Filing Icon  
11/24/2021Ian ClementsCFOBuy700$14.40$10,080.00View SEC Filing Icon  
See Full Table
Trump won. Buy this coin now.
From Weiss Ratings   |   Ad
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
This could be his favorite coin.

SEC Filings (Institutional Ownership Changes) for Mirum Pharmaceuticals (NASDAQ:MIRM)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MIRM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Mirum Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/16/2024Geode Capital Management LLC936,197$36.52M0.0%+3.2%1.950%Search for SEC Filing on Google Icon
11/15/2024Frazier Life Sciences Management L.P.6,570,392$256.25M10.3%+1.2%13.687%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC245,918$9.59M0.0%+4.6%0.512%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd5,516$0.22M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP122,334$4.77M0.0%+62.2%0.255%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,793,728$69.96M0.0%+19.9%3.737%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC4,480,284$174.74M0.1%-10.2%9.333%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC13,571$0.53M0.2%-32.8%0.028%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH260,000$10.14M0.1%N/A0.545%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC113,712$4.44M0.4%+188.9%0.238%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC3,445,363$134.37M2.3%-24.5%7.221%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC63,461$2.48M0.0%+5.7%0.133%Search for SEC Filing on Google Icon
11/14/2024FORA Capital LLC10,226$0.40M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/13/2024Loomis Sayles & Co. L P499,316$19.47M0.0%N/A1.047%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.328,161$12.80M0.0%+5.5%0.688%Search for SEC Filing on Google Icon
11/12/2024HealthInvest Partners AB138,321$5.40M2.5%+83.9%0.290%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC12,733$0.50M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.67,375$2.63M0.0%+46.9%0.141%Search for SEC Filing on Google Icon
11/8/2024Phocas Financial Corp.37,889$1.48M0.0%-37.3%0.079%Search for SEC Filing on Google Icon
11/7/2024First Turn Management LLC647,611$25.26M4.0%-7.9%1.357%Search for SEC Filing on Google Icon
11/5/2024GSA Capital Partners LLP57,985$2.26M0.2%+791.7%0.122%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC45,000$1.76M1.3%-29.7%0.094%Search for SEC Filing on Google Icon
10/28/2024Rice Hall James & Associates LLC242,711$9.47M0.5%+5.7%0.515%Search for SEC Filing on Google Icon
10/25/2024Golden State Equity Partners19,380$0.76M0.2%-2.8%0.041%Search for SEC Filing on Google Icon
10/25/2024China Universal Asset Management Co. Ltd.9,176$0.36M0.0%+65.7%0.019%Search for SEC Filing on Google Icon
10/23/2024Mirae Asset Global Investments Co. Ltd.1,725$67K0.0%+22.6%0.004%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.23,725$0.93M0.5%+20.1%0.050%Search for SEC Filing on Google Icon
10/23/2024Hennion & Walsh Asset Management Inc.116,054$4.53M0.2%+10.8%0.246%Search for SEC Filing on Google Icon
10/18/2024Raymond James & Associates137,628$5.37M0.0%-4.6%0.292%Search for SEC Filing on Google Icon
10/16/2024Secure Asset Management LLC36,514$1.42M0.2%-20.5%0.077%Search for SEC Filing on Google Icon
10/11/2024Creative Planning6,382$0.25M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/27/2024Clearbridge Investments LLC699,933$23.93M0.0%+165.5%1.485%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company22,134$0.76M0.0%-49.9%0.047%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC265,443$9.08M0.0%-50.8%0.563%Search for SEC Filing on Google Icon
8/15/2024AQR Capital Management LLC8,294$0.28M0.0%-74.1%0.018%Search for SEC Filing on Google Icon
8/15/2024AXA S.A.425,992$14.57M0.0%-28.3%0.904%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC155,000$5.30M0.6%-3.1%0.329%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC67,421$2.31M0.0%+63.4%0.143%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP20,520$0.70M0.0%+35.9%0.044%Search for SEC Filing on Google Icon
8/14/2024ProShare Advisors LLC6,224$0.21M0.0%N/A0.013%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC13,008$0.45M0.0%-68.2%0.028%Search for SEC Filing on Google Icon
8/12/2024XTX Topco Ltd15,245$0.52M0.0%N/A0.032%Search for SEC Filing on Google Icon
8/12/2024Amalgamated Bank1,357$46K0.0%+60.8%0.003%Search for SEC Filing on Google Icon
8/8/2024William Blair Investment Management LLC677,939$23.18M0.1%+8.1%1.438%Search for SEC Filing on Google Icon
8/8/2024Federated Hermes Inc.5,400$0.19M0.0%-40.0%0.011%Search for SEC Filing on Google Icon
8/8/2024First Turn Management LLC703,398$24.05M3.9%-26.6%1.492%Search for SEC Filing on Google Icon
8/8/2024Ground Swell Capital LLC10,780$0.37M0.3%N/A0.023%Search for SEC Filing on Google Icon
8/8/2024Rice Hall James & Associates LLC229,730$7.85M0.5%+6.9%0.487%Search for SEC Filing on Google Icon
8/6/2024Quest Partners LLC1,142$39K0.0%+7,513.3%0.002%Search for SEC Filing on Google Icon
8/6/2024Candriam S.C.A.508,475$17.38M0.1%N/A1.079%Search for SEC Filing on Google Icon
8/5/2024Arizona State Retirement System9,210$0.32M0.0%+10.6%0.020%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers52,916$1.81M0.0%+48.5%0.112%Search for SEC Filing on Google Icon
7/31/2024Commonwealth Equity Services LLC14,050$0.48M0.0%+17.1%0.030%Search for SEC Filing on Google Icon
7/29/2024Principal Financial Group Inc.7,001$0.24M0.0%-15.9%0.015%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp143,000$4.89M0.0%+48.2%0.303%Search for SEC Filing on Google Icon
7/26/2024AlphaCentric Advisors LLC64,000$2.19M1.6%-31.9%0.136%Search for SEC Filing on Google Icon
7/24/2024Secure Asset Management LLC45,904$1.57M0.3%+8.6%0.097%Search for SEC Filing on Google Icon
7/20/2024Hennion & Walsh Asset Management Inc.104,770$3.58M0.2%+64.9%0.222%Search for SEC Filing on Google Icon
7/19/2024Raymond James & Associates144,214$4.93M0.0%+10.5%0.306%Search for SEC Filing on Google Icon
7/19/2024Values First Advisors Inc.19,754$0.68M0.4%-7.7%0.042%Search for SEC Filing on Google Icon
7/16/2024Wealth Enhancement Advisory Services LLC16,409$0.56M0.0%-47.9%0.035%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System86,992$2.19M0.0%-58.8%0.185%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC2,767,210$69.47M0.0%+34.2%5.871%Search for SEC Filing on Google Icon
5/16/2024Silvercrest Asset Management Group LLC162,817$4.09M0.0%+64.6%0.345%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD1,597,506$40.13M0.0%+37.2%3.390%Search for SEC Filing on Google Icon
5/15/2024Affinity Asset Advisors LLC160,000$4.02M0.5%+220.0%0.339%Search for SEC Filing on Google Icon
5/13/2024Clearbridge Investments LLC263,584$6.62M0.0%-0.2%0.559%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,211,685$55.56M0.0%-10.7%4.694%Search for SEC Filing on Google Icon
5/8/2024William Blair Investment Management LLC627,272$15.76M0.0%+0.9%1.331%Search for SEC Filing on Google Icon
5/8/2024Russell Investments Group Ltd.17,481$0.44M0.0%+11.7%0.037%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC14,812$0.37M0.0%-38.5%0.031%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.18,641$0.45M0.0%+7.2%0.040%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC18,455$0.46M0.0%-20.0%0.039%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.8,952$0.23M0.0%+66.0%0.019%Search for SEC Filing on Google Icon
4/23/2024Wetzel Investment Advisors Inc.2,400$57K0.0%+71.4%0.005%Search for SEC Filing on Google Icon
4/23/2024Rice Hall James & Associates LLC214,887$5.40M0.3%+401.6%0.457%Search for SEC Filing on Google Icon
4/23/2024Raymond James Financial Services Advisors Inc.97,891$2.46M0.0%+63.0%0.208%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC18,455$0.46M0.0%-20.0%0.039%Search for SEC Filing on Google Icon
4/17/2024Hennion & Walsh Asset Management Inc.63,534$1.60M0.1%+31.0%0.135%Search for SEC Filing on Google Icon
4/16/2024Wealth Enhancement Advisory Services LLC31,489$0.79M0.0%-2.7%0.067%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC41,836$1.05M0.0%+10.8%0.089%Search for SEC Filing on Google Icon
3/21/2024Healthcare of Ontario Pension Plan Trust Fund211,949$6.26M0.0%+111.9%0.451%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC6,881$0.20M0.0%-18.5%0.015%Search for SEC Filing on Google Icon
2/26/2024Perceptive Advisors LLC534,942$15.79M0.4%-20.4%1.148%Search for SEC Filing on Google Icon
2/20/2024Eventide Asset Management LLC2,663,649$78.63M1.3%-32.7%5.715%Search for SEC Filing on Google Icon
2/15/2024Octagon Capital Advisors LP25,000$0.74M0.1%N/A0.054%Search for SEC Filing on Google Icon
2/15/2024Frazier Life Sciences Management L.P.6,495,392$191.74M10.3%+0.4%13.934%Search for SEC Filing on Google Icon
2/15/2024Boone Capital Management LLC490,139$14.47M3.4%+25.7%1.051%Search for SEC Filing on Google Icon
2/14/2024Cadian Capital Management LP1,934,922$57.12M2.3%+34.8%4.151%Search for SEC Filing on Google Icon
2/14/2024Partners Group Holding AG18,271$0.54M0.1%N/A0.039%Search for SEC Filing on Google Icon
2/14/2024StepStone Group LP4,568$0.14M0.0%N/A0.010%Search for SEC Filing on Google Icon
2/14/2024CenterBook Partners LP51,837$1.53M0.2%+242.4%0.111%Search for SEC Filing on Google Icon
2/13/2024Affinity Asset Advisors LLC50,000$1.48M0.3%+66.7%0.107%Search for SEC Filing on Google Icon
2/13/2024Rafferty Asset Management LLC130,346$3.85M0.0%-5.0%0.280%Search for SEC Filing on Google Icon
2/13/2024NEOS Investment Management LLC7,442$0.22M0.0%N/A0.016%Search for SEC Filing on Google Icon
2/13/2024California State Teachers Retirement System211,111$6.23M0.0%+672.9%0.453%Search for SEC Filing on Google Icon
2/12/2024TD Asset Management Inc47,000$1.39M0.0%N/A0.101%Search for SEC Filing on Google Icon
2/12/2024Steward Partners Investment Advisory LLC39,550$1.17M0.0%+31.6%0.085%Search for SEC Filing on Google Icon
2/9/2024Franklin Resources Inc.913,068$26.95M0.0%+22.6%1.959%Search for SEC Filing on Google Icon
2/9/2024Quest Partners LLC6,563$0.19M0.0%N/A0.014%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Mirum Pharmaceuticals logo
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.
Read More on Mirum Pharmaceuticals

Today's Range

Now: $43.69
Low: $41.40
High: $44.08

50 Day Range

MA: $40.17
Low: $37.85
High: $46.26

52 Week Range

Now: $43.69
Low: $23.14
High: $48.89

Volume

450,893 shs

Average Volume

558,714 shs

Market Capitalization

$2.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16

Who are the company insiders with the largest holdings of Mirum Pharmaceuticals?

Mirum Pharmaceuticals' top insider investors include:
  1. Patrick J Heron (Director)
  2. Christopher Peetz (CEO)
  3. Lara Longpre (Insider)
  4. Peter Radovich (COO)
  5. Pamela Vig (Insider)
  6. Eric Bjerkholt (CFO)
  7. Jolanda Howe (SVP)
  8. Michael G Grey (Director)
  9. Saira Ramasastry (Director)
Learn More about top insider investors at Mirum Pharmaceuticals.

Who are the major institutional investors of Mirum Pharmaceuticals?

Mirum Pharmaceuticals' top institutional investors include:
  1. Frazier Life Sciences Management L.P. — 13.69%
  2. Janus Henderson Group PLC — 9.33%
  3. Eventide Asset Management LLC — 7.22%
  4. State Street Corp — 3.74%
  5. Geode Capital Management LLC — 1.95%
  6. First Turn Management LLC — 1.36%
Learn More about top institutional investors of Mirum Pharmaceuticals stock.

Which institutional investors are selling Mirum Pharmaceuticals stock?

During the last quarter, MIRM stock was sold by these institutional investors:
  1. Eventide Asset Management LLC
  2. Janus Henderson Group PLC
  3. First Turn Management LLC
  4. Phocas Financial Corp.
  5. AlphaCentric Advisors LLC
  6. Secure Asset Management LLC
  7. HighVista Strategies LLC
  8. Raymond James & Associates
Within the last year, company insiders that have sold Mirum Pharmaceuticals company stock include:
  1. Patrick J Heron (Director)
  2. Christopher Peetz (CEO)
  3. Lara Longpre (Insider)
  4. Peter Radovich (COO)
  5. Pamela Vig (Insider)
  6. Eric Bjerkholt (CFO)
Learn More investors selling Mirum Pharmaceuticals stock.

Which institutional investors are buying Mirum Pharmaceuticals stock?

In the last quarter, MIRM stock was bought by institutional investors including:
  1. Loomis Sayles & Co. L P
  2. State Street Corp
  3. Erste Asset Management GmbH
  4. Jane Street Group LLC
  5. Frazier Life Sciences Management L.P.
  6. PDT Partners LLC
  7. HealthInvest Partners AB
  8. GSA Capital Partners LLP
Within the last year, these company insiders have bought Mirum Pharmaceuticals stock:
  1. Patrick J Heron (Director)
  2. Christopher Peetz (CEO)
Learn More investors buying Mirum Pharmaceuticals stock.
When it comes to NVDA… “acceleration cycles” are the key
From DTI   |   Ad
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
Use this link to see Nvidia Unchained right away!